Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
FATE THERAPEUTICS INC entered into Open Market Sale Agreement with Jefferies LLC valued at up to $100,000,000 (effective 2023-11-08).
- Action
- entry
- Agreement
- atm program
- Counterparty
- Jefferies LLC
- Value
- up to $100,000,000
- Effective
- 2023-11-08
Exact text from the filing
on November 8, 2023, the Company entered into an Open Market Sale Agreement SM (the “Agreement”) with Jefferies LLC (“Jefferies”) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its Common Stock having an aggregate offering price of up to $100,000,000 (the “Placement Shares”), through Jefferies as its sales agent.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
FATE THERAPEUTICS INC terminated Open Market Sale Agreement with Jefferies LLC (effective 2023-11-08).
- Action
- termination
- Agreement
- atm program
- Counterparty
- Jefferies LLC
- Effective
- 2023-11-08
Exact text from the filing
Effective upon the execution of the Agreement, the Open Market Sale Agreement SM , dated November 4, 2021, by and between the Company and Jefferies (the “Prior Agreement”), was terminated and superseded by the Agreement.
View on SEC.gov